Market Place
Sourcing Support
Msn’s Generics Glycerol Phenylbutyrate Receives Approval in US
15 Apr 2026 //
FDA
Msn’s Generics Dapagliflozin & Saxagliptin Receive Approval in US
06 Apr 2026 //
FDA
MSN’s Generics Dapagliflozin & Metformin Receives Approval in US
06 Apr 2026 //
FDA
MSN’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
MSN Pharma’s Generics Afatinib Receives Approval in US
18 Feb 2026 //
FDA
MSN’s Generics Bumetanide Receives Approval in US
05 Feb 2026 //
FDA
MSN’s Generics Metformin HCl Receives Tentative Approval in US
27 Jan 2026 //
FDA
MSN’s Generics Chlorpromazine HCl Receives Approval in US
26 Jan 2026 //
FDA
MSN’s Generics Selexipag Receives Tentative Approval in US
16 Jan 2026 //
FDA
Msn’s Generics Eltrombopag Olamine Receives Approval in US
14 Jan 2026 //
FDA
MSN’s Generics Norepinephrine Bitartrate Receives Approval in US
11 Dec 2025 //
FDA
MSN’s Generics Brivaracetam Receives Tentative Approval in US
01 Dec 2025 //
FDA
Msn’s Generics Nilotinib HCl Receives Approval in US
19 Nov 2025 //
FDA
Msn’s Generics Sitagliptin & Metformin Receives Approval in US
17 Nov 2025 //
FDA
MSN’s Generics Brivaracetam Receives Approval in US
13 Nov 2025 //
FDA
MSN Lab’s Generics Vibegron Receives Tentative Approval In US
04 Nov 2025 //
FDA
MSN’s Generics Irbesartan Receives Approval in US
04 Nov 2025 //
FDA
MSN’s Generics Mirabegron Receives Approval in US
04 Nov 2025 //
FDA
MSN’s Generics Vortioxetine HBr Receives Tentative Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Linagliptin, Metformin HCl Receives Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Linagliptin Receives Approval in US
03 Nov 2025 //
FDA
MSN’s Generics Rivaroxaban Receives Approval in US
24 Oct 2025 //
FDA
MSN’s Generics Dapagliflozin Receive Tentative Approval in US
05 Sep 2025 //
FDA
MSN’s Receives First Generic Approval for Baricitinib in US
08 Aug 2025 //
FDA
MSN`s Generics Famotidine Receives Approval in US
24 Jul 2025 //
FDA
MSN`s Generics Sitagliptin Receives Tentative Approval in US
23 Jul 2025 //
FDA
MSN’s Receives First Generic Approval for Perampanel in US
11 Jul 2025 //
FDA
MSN`s Generics Sacubitril Receives Tentative Approval in US
29 May 2025 //
FDA
MSN`s Generics Posaconazole Receives Approval in US
24 Feb 2025 //
FDA
MSN`s Generics Lofexidine HCl Receives Approval in US
24 Feb 2025 //
FDA
MSN Lab`s Generics Perampanel Receive Tentative Approval in US
08 Jan 2025 //
FDA
MSN Lab`s Generics Perampanel Receives Tentative Approval in US
16 Dec 2024 //
FDA
MSN`s Generics Nilotinib Receives Tentative Approval in US
02 Oct 2024 //
FDA
MSN`s Generics Nebivolol HCl Receives Approval in US
01 Oct 2024 //
FDA
MSN`s Generics Clopidogrel Bisulfate Receives Approval in US
20 Sep 2024 //
FDA
MSN Laboratories`s Generics Famotidine Receives Approval in US
06 Aug 2024 //
FDA
MSN Labs` Generic Azacitidine Receives Approval in the U.S.
16 May 2024 //
FDA
MSN`s Generic Lisdexamfetamine Dimesylate Receives Approval in the U.S.
02 Feb 2024 //
FDA
MSN`s Generic Pimavanserin Receives Approval in the U.S.
16 Jan 2024 //
FDA
MSN Lab`s Generic Brivaracetam Receives Approval in the U.S.
09 Nov 2023 //
FDA
MSN Laboratories` Generic Brivaracetam Receives Approval in the U.S.
09 Nov 2023 //
FDA
MSN Laboratories` Generic Trabectedin Receives Approval in the U.S.
02 Oct 2023 //
FDA
MSN`s Generic Losartan Potassium Receives Approval in the U.S.
14 Aug 2023 //
FDA
MSN Lab`s Generic Etelcalcetide Receives Approval in the U.S.
03 Aug 2023 //
FDA
MSN`s Generic Darunavir Receives Approval in the U.S.
05 Jul 2023 //
FDA
MSN`s Generic Obeticholic Acid Receives Receives Approval in the U.S.
30 May 2023 //
FDA
MSN Lab`s Generic Carmustine Receives Receives Approval in the U.S.
11 May 2023 //
FDA
MSN Lab`s Generic Ribociclib Receives Receives Approval in the U.S.
09 May 2023 //
FDA
MSN Lab Generic Letrozole:Ribociclib Receives Approval in the U.S
01 May 2023 //
FDA
MSN`s Generic Doxepin Hydrochloride Receives Approval in the U.S.
03 Apr 2023 //
FDA
MSN`s Generic Acyclovir Receives Approval in the U.S.
09 Mar 2023 //
FDA
MSN`s Generic Afatinib Receives Approval in the U.S.
14 Feb 2023 //
FDA
MSN`s Generic Lacosamide Receives Approval in the U.S.
09 Feb 2023 //
FDA
MSN`s Generic Olmesartan Medoxomil Receives Approval in the U.S.
18 Jan 2023 //
FDA
MSN`s Generic Tasimelteon Receives Approval in the U.S.
12 Jan 2023 //
FDA
MSN`s Generic Haloperidol Receives Approval in the U.S.
18 Nov 2022 //
FDA
MSN`s Generic Levetiracetam Receives Approval in the U.S.
15 Nov 2022 //
FDA
MSN`s Generic Levetiracetam Receives Approval in the U.S.
07 Oct 2022 //
FDA
MSN`s Generic Isosulfan Blue Receives Approval in the U.S.
16 Sep 2022 //
FDA
